Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country

Leuk Lymphoma. 2021 Jun;62(6):1514-1517. doi: 10.1080/10428194.2020.1867724. Epub 2021 Jan 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Azacitidine*
  • Bridged Bicyclo Compounds, Heterocyclic
  • Developing Countries
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Sulfonamides

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Azacitidine
  • venetoclax